These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30787877)

  • 1. Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.
    Bartmann L; Schumacher D; von Stillfried S; Sternkopf M; Alampour-Rajabi S; van Zandvoort MAMJ; Kiessling F; Wu Z
    Front Pharmacol; 2019; 10():79. PubMed ID: 30787877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboflavin-Targeted Drug Delivery.
    Darguzyte M; Drude N; Lammers T; Kiessling F
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32012715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in riboflavin transporter RFVT and its genetic disease.
    Jin C; Yonezawa A
    Pharmacol Ther; 2022 May; 233():108023. PubMed ID: 34662687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers.
    Tsvetkova Y; Beztsinna N; Baues M; Klein D; Rix A; Golombek SK; Al Rawashdeh W; Gremse F; Barz M; Koynov K; Banala S; Lederle W; Lammers T; Kiessling F
    Nano Lett; 2017 Aug; 17(8):4665-4674. PubMed ID: 28715227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Expression of Riboflavin Transporters in Human Colorectal Cancer.
    Tutino V; Defrancesco ML; Tolomeo M; DE Nunzio V; Lorusso D; Paleni D; Caruso MG; Notarnicola M; Barile M
    Anticancer Res; 2018 May; 38(5):2659-2667. PubMed ID: 29715086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riboflavin Transporters RFVT/SLC52A Mediate Translocation of Riboflavin, Rather than FMN or FAD, across Plasma Membrane.
    Jin C; Yao Y; Yonezawa A; Imai S; Yoshimatsu H; Otani Y; Omura T; Nakagawa S; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2017; 40(11):1990-1995. PubMed ID: 29093349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Riboflavin Targeting on Tumor Accumulation and Internalization of Peptostar Based Drug Delivery Systems.
    Darguzyte M; Holm R; Baier J; Drude N; Schultze J; Koynov K; Schwiertz D; Dadfar SM; Lammers T; Barz M; Kiessling F
    Bioconjug Chem; 2020 Dec; 31(12):2691-2696. PubMed ID: 33237762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52.
    Yonezawa A; Inui K
    Mol Aspects Med; 2013; 34(2-3):693-701. PubMed ID: 23506902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.
    Bartmann L; Schumacher D; von Stillfried S; Sternkopf M; Alampour-Rajabi S; van Zandvoort MAMJ; Kiessling F; Wu Z
    Front Pharmacol; 2020; 11():617329. PubMed ID: 33324229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin.
    Rizzo F; Ramirez A; Compagnucci C; Salani S; Melzi V; Bordoni A; Fortunato F; Niceforo A; Bresolin N; Comi GP; Bertini E; Nizzardo M; Corti S
    Sci Rep; 2017 Apr; 7():46271. PubMed ID: 28382968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic Phospholipid-Based Riboflavin Derivatives for Tumor Targeting Nanomedicines.
    Beztsinna N; Tsvetkova Y; Bartneck M; Lammers T; Kiessling F; Bestel I
    Bioconjug Chem; 2016 Sep; 27(9):2048-61. PubMed ID: 27412680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of riboflavin transporter RFVT2/Slc52a2 in hepatic homeostasis of riboflavin in mice.
    Yao Y; Yonezawa A; Yoshimatsu H; Omura T; Masuda S; Matsubara K
    Eur J Pharmacol; 2013 Aug; 714(1-3):281-7. PubMed ID: 23911957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.
    Beztsinna N; Tsvetkova Y; Jose J; Rhourri-Frih B; Al Rawashdeh W; Lammers T; Kiessling F; Bestel I
    Int J Nanomedicine; 2017; 12():3813-3825. PubMed ID: 28572726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Identification of a Key Residue for Substrate Recognition of the Riboflavin Membrane Transporter RFVT3.
    Dilly S; Garnier M; Solé M; Bailly R; Taib N; Bestel I
    J Chem Inf Model; 2020 Mar; 60(3):1368-1375. PubMed ID: 31922414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation.
    Kansara V; Pal D; Jain R; Mitra AK
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):275-87. PubMed ID: 16117691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riboflavin-targeted polymer conjugates for breast tumor delivery.
    Bareford LM; Avaritt BR; Ghandehari H; Nan A; Swaan PW
    Pharm Res; 2013 Jul; 30(7):1799-812. PubMed ID: 23568523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riboflavin transport mediated by riboflavin transporters (RFVTs/SLC52A) at the rat outer blood-retinal barrier.
    Kubo Y; Miki S; Akanuma SI; Hosoya KI
    Drug Metab Pharmacokinet; 2019 Dec; 34(6):380-386. PubMed ID: 31601465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riboflavin-mediated delivery of a macromolecule into cultured human cells.
    Holladay SR; Yang Z; Kennedy MD; Leamon CP; Lee RJ; Jayamani M; Mason T; Low PS
    Biochim Biophys Acta; 1999 Jan; 1426(1):195-204. PubMed ID: 9878734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption.
    Subramanian VS; Lambrecht N; Lytle C; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G285-93. PubMed ID: 26660539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-to-retina transport of riboflavin via RFVTs at the inner blood-retinal barrier.
    Kubo Y; Yahata S; Miki S; Akanuma SI; Hosoya KI
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):92-99. PubMed ID: 27964953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.